chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: arm was sore; she was probably in bed with overwhelming low energy; general achiness; vertigo/ vertigo was pretty severe/ vertigo was on and off; she thinks she received expired vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was sore), ASTHENIA (she was probably in bed with overwhelming low energy), PAIN (general achiness), VERTIGO (vertigo/ vertigo was pretty severe/ vertigo was on and off) and EXPIRED PRODUCT ADMINISTERED (she thinks she received expired vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (she thinks she received expired vaccine). On 03-Apr-2021, the patient experienced VERTIGO (vertigo/ vertigo was pretty severe/ vertigo was on and off). On an unknown date, the patient experienced PAIN IN EXTREMITY (arm was sore), ASTHENIA (she was probably in bed with overwhelming low energy) and PAIN (general achiness). On 30-Mar-2021, EXPIRED PRODUCT ADMINISTERED (she thinks she received expired vaccine) had resolved. In August 2021, VERTIGO (vertigo/ vertigo was pretty severe/ vertigo was on and off) had resolved. At the time of the report, PAIN IN EXTREMITY (arm was sore), ASTHENIA (she was probably in bed with overwhelming low energy) and PAIN (general achiness) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Antibody test: negative (Negative) IgG and IgM, negative, was explained patient has zero antibodies and negative (Negative) IgG and IgM, negative.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was reported. Patient had to use medication for the vertigo.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Decreased appetite, Diarrhoea, Myalgia
Clinical narrative: lack of appetite; lack of energy; diarrhea; Aches/ pains; nausea; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (lack of appetite), ASTHENIA (lack of energy), DIARRHOEA (diarrhea), MYALGIA (Aches/ pains) and NAUSEA (nausea) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced DECREASED APPETITE (lack of appetite), ASTHENIA (lack of energy), DIARRHOEA (diarrhea), MYALGIA (Aches/ pains), NAUSEA (nausea), PYREXIA (fever) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DECREASED APPETITE (lack of appetite), ASTHENIA (lack of energy), DIARRHOEA (diarrhea), MYALGIA (Aches/ pains), NAUSEA (nausea), PYREXIA (fever) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The concomitant medication was not reported.  Patient quit smoking 14 years ago.   This case was linked to MOD-2021-341298 (Patient Link).
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: lack of appetite; lack of energy; diarrhea; Aches/ pains; nausea; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (lack of appetite), ASTHENIA (lack of energy), DIARRHOEA (diarrhea), MYALGIA (Aches/ pains) and NAUSEA (nausea) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced DECREASED APPETITE (lack of appetite), ASTHENIA (lack of energy), DIARRHOEA (diarrhea), MYALGIA (Aches/ pains), NAUSEA (nausea), PYREXIA (fever) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DECREASED APPETITE (lack of appetite), ASTHENIA (lack of energy), DIARRHOEA (diarrhea), MYALGIA (Aches/ pains), NAUSEA (nausea), PYREXIA (fever) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The concomitant medication was not reported.  Patient quit smoking 14 years ago.   This case was linked to MOD-2021-341298 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test
Clinical narrative: Runny nose; This spontaneous case was reported by a nurse and describes the occurrence of RHINORRHOEA (Runny nose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RHINORRHOEA (Runny nose). At the time of the report, RHINORRHOEA (Runny nose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient completed his 3 doses of Moderna COVID vaccine as well around June or July.  No relevant concomitant medications were reported. No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: administered an expired vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered an expired vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered an expired vaccine). On 02-Oct-2021, EXPIRED PRODUCT ADMINISTERED (administered an expired vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication details were not reported by the reporter.  Treatment details was not reported by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: wife to get the doses in less than a month.; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (wife to get the doses in less than a month.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Oct-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (wife to get the doses in less than a month.). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (wife to get the doses in less than a month.) outcome was unknown.            No concomitant and treatment medication were reported.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Skin ulcer
Clinical narrative: Venous stasis ulcer; This spontaneous case was reported by a consumer and describes the occurrence of SKIN ULCER (Venous stasis ulcer) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 031M20A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: FLUZONE HIGH DOSE QUADRIVALENT (route Intramuscular,Body site left deltoid and dose 1) on 09-Sep-2021. Concurrent medical conditions included Hypertensive heart disease (controlled via medication) since 11-Jul-2008, Sleep apnea (controlled by Bi-PAP) since 20-Aug-2009, Obesity (losing weight) since 15-Jul-2004, Seronegative rheumatoid arthritis (increased dosage of methotrexate) since 07-Feb-2019, Osteoarthritis (increased dosage of methotrexate) since 07-Feb-2019 and Adhesive tape allergy. Concomitant products included FOLIC ACID for Anaemia, DULOXETINE, ACETAMINOPHEN, GLUCOSAMINE and CHONDROITIN for Arthritis, POTASSIUM CHLORIDE for Electrolyte substitution therapy, NIACIN for High cholesterol, FAMOTIDINE for Hyperchlorhydria, ATENOLOL, DILTIAZEM, MINOXIDIL, OLMESARTAN MEDOXOMIL and TORSEMIDE for Hypertension, ZOLPIDEM TARTRATE (ZOLPIDEM TARTRATE ACTAVIS) for Insomnia, MOMETASONE FUROATE (MOMETASONE FUROATE CIPLA) for Nasal congestion, METHOTREXATE for Rheumatoid arthritis, MONTELUKAST SODIUM for Rhinitis allergic, MULTIVITAMIN & MINERAL, VITAMIN D3 and VITAMIN C [ASCORBIC ACID] for an unknown indication.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Sep-2021, the patient experienced SKIN ULCER (Venous stasis ulcer). The patient was treated with CARMELLOSE SODIUM (DUODERM CGF [CARMELLOSE SODIUM]) for Venous stasis ulcer, at an unspecified dose and frequency. At the time of the report, SKIN ULCER (Venous stasis ulcer) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-338635 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: received a dose of moderna after the BUD (beyond use date); This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received a dose of Moderna after the BUD (beyond use date)) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (received a dose of moderna after the BUD (beyond use date)). At the time of the report, EXPIRED PRODUCT ADMINISTERED (received a dose of moderna after the BUD (beyond use date)) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: weird symptoms; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (weird symptoms) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced VACCINATION COMPLICATION (weird symptoms). At the time of the report, VACCINATION COMPLICATION (weird symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Adnexa uteri pain, Lymphadenopathy
Clinical narrative: Her left armpit felt painful/she has pain under her left arm, there was like a little nodule/ size of a golf ball under her left armpit/ Her lymph nodes are swollen; left ovary cramping/left ovary painful/left ovary felt like it wanted to burst; This spontaneous case was reported by a consumer and describes the occurrence of ADNEXA UTERI PAIN (left ovary cramping/left ovary painful/left ovary felt like it wanted to burst) and LYMPHADENOPATHY (Her left armpit felt painful/she has pain under her left arm, there was like a little nodule/ size of a golf ball under her left armpit/ Her lymph nodes are swollen) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination.     The patient's past medical history included Tubectomy (tubes tied years ago, no possibility of a pregnancy.).    On 29-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Sep-2021, the patient experienced ADNEXA UTERI PAIN (left ovary cramping/left ovary painful/left ovary felt like it wanted to burst). On 03-Oct-2021, the patient experienced LYMPHADENOPATHY (Her left armpit felt painful/she has pain under her left arm, there was like a little nodule/ size of a golf ball under her left armpit/ Her lymph nodes are swollen). On 02-Oct-2021, ADNEXA UTERI PAIN (left ovary cramping/left ovary painful/left ovary felt like it wanted to burst) had resolved. At the time of the report, LYMPHADENOPATHY (Her left armpit felt painful/she has pain under her left arm, there was like a little nodule/ size of a golf ball under her left armpit/ Her lymph nodes are swollen) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication information were provided. No treatment information provided.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Nasopharyngitis, Pyrexia
Clinical narrative: cold; shivering; low-grade fever; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (cold), CHILLS (shivering) and PYREXIA (low-grade fever) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008B21A and 031A21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (cold), CHILLS (shivering) and PYREXIA (low-grade fever). At the time of the report, NASOPHARYNGITIS (cold), CHILLS (shivering) and PYREXIA (low-grade fever) outcome was unknown.            Concomitant: Inhaler for asthma No treatment information was provided   This case was linked to MOD-2021-341921 (Patient Link).
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Nasopharyngitis, Pyrexia
Clinical narrative: He had cold; He was shivering/cold shivers; He had low-grade fever; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (He had cold), CHILLS (He was shivering/cold shivers) and PYREXIA (He had low-grade fever) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019F21A, 008B21A and 031A21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Oct-2021, the patient experienced NASOPHARYNGITIS (He had cold), CHILLS (He was shivering/cold shivers) and PYREXIA (He had low-grade fever). At the time of the report, NASOPHARYNGITIS (He had cold) and PYREXIA (He had low-grade fever) was resolving and CHILLS (He was shivering/cold shivers) had not resolved.            Concomitant drug included inhaler for asthma. Treatment medications were not provided.  It was reported that patient was not feeling as bad.   This case was linked to MOD-2021-341881 (Patient Link).
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Fall, Myalgia, Pain
Clinical narrative: fell on her back/fell on the back of her head; has a lot of pain from the fall; muscle pain from the fall; This spontaneous case was reported by a consumer and describes the occurrence of FALL (fell on her back/fell on the back of her head), PAIN (has a lot of pain from the fall) and MYALGIA (muscle pain from the fall) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FALL (fell on her back/fell on the back of her head), PAIN (has a lot of pain from the fall) and MYALGIA (muscle pain from the fall). At the time of the report, FALL (fell on her back/fell on the back of her head), PAIN (has a lot of pain from the fall) and MYALGIA (muscle pain from the fall) outcome was unknown.            No concomitant medications were reported No treatment medications were reported.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: receiving dose from an expired Moderna COVID19 vaccine vial; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (receiving dose from an expired Moderna COVID19 vaccine vial) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037b21a) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (receiving dose from an expired Moderna COVID19 vaccine vial). On 04-Oct-2021, EXPIRED PRODUCT ADMINISTERED (receiving dose from an expired Moderna COVID19 vaccine vial) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No  Concomitant medications were provided.  Reporter stated that 4 doses of 1 expired vial of the Moderna COVID19 vaccine were administered   No Treatment medications were provided.
Sex: U
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: throwing up; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (throwing up) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VOMITING (throwing up). At the time of the report, VOMITING (throwing up) outcome was unknown.            The concomitant medications included medication shots. No treatment medications were reported.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Invalid dose; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 05-Oct-2021 and was forwarded to Moderna on 05-Oct-2021.    This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Invalid dose) in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: INFLUENZA VACCINE (Lot number 323626) on 27-Sep-2021.   On 04-Oct-2021 at 8:35 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Invalid dose). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Invalid dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment medications reported. The invalid dose of Moderna was pulled out of the freezer on Friday October 1st, 2021. The invalid dose of Moderna expired on Sunday October 3, 2021. The Invalid dose of Moderna was administered on Monday October 4, 2021 at 0835 in the morning into this patient's left arm.   Most recent FOLLOW-UP information incorporated above includes: On 07-Oct-2021: Follow up received: Added new reporter, historical vaccine Influenza AIIV4 added, patient route of administration Intramuscular added.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore injection site arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore injection site arm) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Sore injection site arm). At the time of the report, VACCINATION SITE PAIN (Sore injection site arm) outcome was unknown.            No concomitant medications were provided.  No treatment medications were provided.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm hurts; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm hurts) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050E21A) for COVID-19 vaccination.     Concurrent medical conditions included Back pain.    On 04-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm hurts). At the time of the report, PAIN IN EXTREMITY (arm hurts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Treatment medication was not provided by the reporter.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Fatigue, Insomnia, Malaise, Myalgia
Clinical narrative: Woke up in middle of night and Still not sleeping well; Not eating well; Felt unwell; Muscle pain; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Woke up in middle of night and Still not sleeping well), DECREASED APPETITE (Not eating well), MALAISE (Felt unwell), MYALGIA (Muscle pain) and FATIGUE (Fatigue) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045C21A, 029A21A and 001B21A) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INSOMNIA (Woke up in middle of night and Still not sleeping well), DECREASED APPETITE (Not eating well), MALAISE (Felt unwell), MYALGIA (Muscle pain) and FATIGUE (Fatigue). The patient was treated with AZELASTINE at an unspecified dose and frequency. At the time of the report, INSOMNIA (Woke up in middle of night and Still not sleeping well), DECREASED APPETITE (Not eating well), MALAISE (Felt unwell), MYALGIA (Muscle pain) and FATIGUE (Fatigue) outcome was unknown.            No concomitant medications were reported.   This case was linked to MOD-2021-342370 (Patient Link).
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Adnexa uteri pain, Chest discomfort, Chest pain, Chills, Cough
Clinical narrative: she still feels heavy in her chest; She was coughing while talking; Chest hurt; Ovaries area Hurting; Sweats; Heart palpitation; Swollen Lymph  nodes  in the neck; Hurting Lymph nodes in the neck; Headache; She started heving Chills; Body aches; This spontaneous case was reported by a patient and describes the occurrence of CHEST DISCOMFORT (she still feels heavy in her chest), COUGH (She was coughing while talking), CHEST PAIN (Chest hurt), ADNEXA UTERI PAIN (Ovaries area Hurting) and HYPERHIDROSIS (Sweats) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (She tested positive for COVID-19 disease two weeks prior to vaccination with COVID-19 symptoms, Night sweats and muscle pain) from 22-Aug-2021 to 01-Sep-2021.    On 15-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Sep-2021, the patient experienced COUGH (She was coughing while talking), CHEST PAIN (Chest hurt), ADNEXA UTERI PAIN (Ovaries area Hurting), HYPERHIDROSIS (Sweats), PALPITATIONS (Heart palpitation), LYMPHADENOPATHY (Swollen Lymph  nodes  in the neck), LYMPH NODE PAIN (Hurting Lymph nodes in the neck), HEADACHE (Headache), CHILLS (She started heving Chills) and MYALGIA (Body aches). On an unknown date, the patient experienced CHEST DISCOMFORT (she still feels heavy in her chest). At the time of the report, CHEST DISCOMFORT (she still feels heavy in her chest) had not resolved, COUGH (She was coughing while talking), CHEST PAIN (Chest hurt), ADNEXA UTERI PAIN (Ovaries area Hurting), HYPERHIDROSIS (Sweats), LYMPHADENOPATHY (Swollen Lymph  nodes  in the neck), LYMPH NODE PAIN (Hurting Lymph nodes in the neck), HEADACHE (Headache), CHILLS (She started heving Chills) and MYALGIA (Body aches) outcome was unknown and PALPITATIONS (Heart palpitation) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Aug-2021, SARS-CoV-2 test: positive (Positive) She tested positive for COVID-19 disease.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment details were reported. Patient reported that her doctor (Urgent care) told her that she got her COVID-19 vaccine too early after COVID-19 disease. She does not have a medical history of heart disease.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hyperhidrosis, Lymph node pain, Lymphadenopathy, Myalgia
Clinical narrative: she still feels heavy in her chest; She was coughing while talking; Chest hurt; Ovaries area Hurting; Sweats; Heart palpitation; Swollen Lymph  nodes  in the neck; Hurting Lymph nodes in the neck; Headache; She started heving Chills; Body aches; This spontaneous case was reported by a patient and describes the occurrence of CHEST DISCOMFORT (she still feels heavy in her chest), COUGH (She was coughing while talking), CHEST PAIN (Chest hurt), ADNEXA UTERI PAIN (Ovaries area Hurting) and HYPERHIDROSIS (Sweats) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (She tested positive for COVID-19 disease two weeks prior to vaccination with COVID-19 symptoms, Night sweats and muscle pain) from 22-Aug-2021 to 01-Sep-2021.    On 15-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Sep-2021, the patient experienced COUGH (She was coughing while talking), CHEST PAIN (Chest hurt), ADNEXA UTERI PAIN (Ovaries area Hurting), HYPERHIDROSIS (Sweats), PALPITATIONS (Heart palpitation), LYMPHADENOPATHY (Swollen Lymph  nodes  in the neck), LYMPH NODE PAIN (Hurting Lymph nodes in the neck), HEADACHE (Headache), CHILLS (She started heving Chills) and MYALGIA (Body aches). On an unknown date, the patient experienced CHEST DISCOMFORT (she still feels heavy in her chest). At the time of the report, CHEST DISCOMFORT (she still feels heavy in her chest) had not resolved, COUGH (She was coughing while talking), CHEST PAIN (Chest hurt), ADNEXA UTERI PAIN (Ovaries area Hurting), HYPERHIDROSIS (Sweats), LYMPHADENOPATHY (Swollen Lymph  nodes  in the neck), LYMPH NODE PAIN (Hurting Lymph nodes in the neck), HEADACHE (Headache), CHILLS (She started heving Chills) and MYALGIA (Body aches) outcome was unknown and PALPITATIONS (Heart palpitation) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Aug-2021, SARS-CoV-2 test: positive (Positive) She tested positive for COVID-19 disease.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment details were reported. Patient reported that her doctor (Urgent care) told her that she got her COVID-19 vaccine too early after COVID-19 disease. She does not have a medical history of heart disease.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations, SARS-CoV-2 test
Clinical narrative: she still feels heavy in her chest; She was coughing while talking; Chest hurt; Ovaries area Hurting; Sweats; Heart palpitation; Swollen Lymph  nodes  in the neck; Hurting Lymph nodes in the neck; Headache; She started heving Chills; Body aches; This spontaneous case was reported by a patient and describes the occurrence of CHEST DISCOMFORT (she still feels heavy in her chest), COUGH (She was coughing while talking), CHEST PAIN (Chest hurt), ADNEXA UTERI PAIN (Ovaries area Hurting) and HYPERHIDROSIS (Sweats) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (She tested positive for COVID-19 disease two weeks prior to vaccination with COVID-19 symptoms, Night sweats and muscle pain) from 22-Aug-2021 to 01-Sep-2021.    On 15-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Sep-2021, the patient experienced COUGH (She was coughing while talking), CHEST PAIN (Chest hurt), ADNEXA UTERI PAIN (Ovaries area Hurting), HYPERHIDROSIS (Sweats), PALPITATIONS (Heart palpitation), LYMPHADENOPATHY (Swollen Lymph  nodes  in the neck), LYMPH NODE PAIN (Hurting Lymph nodes in the neck), HEADACHE (Headache), CHILLS (She started heving Chills) and MYALGIA (Body aches). On an unknown date, the patient experienced CHEST DISCOMFORT (she still feels heavy in her chest). At the time of the report, CHEST DISCOMFORT (she still feels heavy in her chest) had not resolved, COUGH (She was coughing while talking), CHEST PAIN (Chest hurt), ADNEXA UTERI PAIN (Ovaries area Hurting), HYPERHIDROSIS (Sweats), LYMPHADENOPATHY (Swollen Lymph  nodes  in the neck), LYMPH NODE PAIN (Hurting Lymph nodes in the neck), HEADACHE (Headache), CHILLS (She started heving Chills) and MYALGIA (Body aches) outcome was unknown and PALPITATIONS (Heart palpitation) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Aug-2021, SARS-CoV-2 test: positive (Positive) She tested positive for COVID-19 disease.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment details were reported. Patient reported that her doctor (Urgent care) told her that she got her COVID-19 vaccine too early after COVID-19 disease. She does not have a medical history of heart disease.
Sex: U
Vaccine: COVID19
Symptoms: Night sweats
Clinical narrative: night sweats; This spontaneous case was reported by a consumer and describes the occurrence of NIGHT SWEATS (night sweats) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NIGHT SWEATS (night sweats). At the time of the report, NIGHT SWEATS (night sweats) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported by the reporter. No treatment information provided.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia
Clinical narrative: feels very tired/extremely fatigued/feels tired all the time; muscle pain; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 05-Oct-2021 and was forwarded to Moderna on 05-Oct-2021.    This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (feels very tired/extremely fatigued/feels tired all the time) and MYALGIA (muscle pain) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Sep-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 3 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 02-Sep-2021, the patient experienced FATIGUE (feels very tired/extremely fatigued/feels tired all the time) and MYALGIA (muscle pain). At the time of the report, FATIGUE (feels very tired/extremely fatigued/feels tired all the time) and MYALGIA (muscle pain) outcome was unknown.            Caller is calling regarding their mother who took the third Moderna COVID-19 vaccine shot on 02Sep2021t as she is immunocompromised. There had passed 5 months and a week between the 2nd and the 3rd shot. She still feels very tired since that date. The caller does not have their mother's card so more details of the doses could not be gathered. The patient had blood tests done to check what could be happening but everything came back normal. country after the shot.  Concomitant medication use was unknown Treatment information was unknown
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia, Vaccination site pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), CHILLS (Chills) and VACCINATION SITE PAIN (Extreme sudden onset pain/discomfort in the arm that the injection occurred/random sudden onset of pain in the upper left arm where the vaccines were given.) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025A21A and 015M20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (sulfa), Food allergy (Oat), Food allergy (possibly some nuts), Asthma (asthma (since childhood)) and Arthritis. Concomitant products included CETIRIZINE HYDROCHLORIDE for Allergy, CHONDROITIN SULFATE, GLUCOSAMINE SULFATE (GLUCOSAMINE & CHONDROITIN SULFATE) for Arthritis, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR) and SALBUTAMOL (VENTOLINE [SALBUTAMOL]) for Asthma, ALBUTEROL [SALBUTAMOL] and VITAMIN C [ASCORBIC ACID] for an unknown indication.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In March 2021, the patient experienced PYREXIA (Fever) and CHILLS (Chills). In May 2021, the patient experienced VACCINATION SITE PAIN (Extreme sudden onset pain/discomfort in the arm that the injection occurred/random sudden onset of pain in the upper left arm where the vaccines were given.). The patient was treated with ACETAMINOPHEN in March 2021 for Chills and Fever, at an unspecified dose and frequency. At the time of the report, PYREXIA (Fever), CHILLS (Chills) and VACCINATION SITE PAIN (Extreme sudden onset pain/discomfort in the arm that the injection occurred/random sudden onset of pain in the upper left arm where the vaccines were given.) outcome was unknown.            The patient reported that the pain in the arm of injection comes in severely and goes away.  This was not triggered by any activities and was very localized. Pain sometimes occurring a few times in a day or week, or once every few weeks also there have been times when I've grabbed my arm as if to sooth the area as one might after being punched, was reported   Most recent FOLLOW-UP information incorporated above includes: On 11-Oct-2021: Follow up document received on 11-OCT-21 contains patient demographics(race, patient height and weight and medical history include arthritis updated. Concomitant drugs updated except Advair and  albuterol.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: had flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (had flu like symptoms) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (had flu like symptoms). At the time of the report, INFLUENZA LIKE ILLNESS (had flu like symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-342263 (Patient Link).
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Inappropriate schedule of product administration
Clinical narrative: Received both doses only 2 weeks apart; Both doses were expired; This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received both doses only 2 weeks apart) and EXPIRED PRODUCT ADMINISTERED (Both doses were expired) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A and 002A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Oct-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Oct-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received both doses only 2 weeks apart) and EXPIRED PRODUCT ADMINISTERED (Both doses were expired). On 01-Oct-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received both doses only 2 weeks apart) and EXPIRED PRODUCT ADMINISTERED (Both doses were expired) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient received the 2 doses with less than 25 days apart, and both of them were expired.  No concomitant medications were reported.  No treatment information was reported   This case was linked to MOD-2021-343937 (Patient Link).
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Asthenia, Fatigue, Feeding disorder, Headache, Injection site erythema
Clinical narrative: Fatigue, sore throat, weakness,  myalgia , pain in arm at the site, low grade fever, headache, itchy, scalp and body itchy, injection site red and swollen. Can't eat.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site pain, Injection site swelling, Myalgia, Oropharyngeal pain, Pruritus
Clinical narrative: Fatigue, sore throat, weakness,  myalgia , pain in arm at the site, low grade fever, headache, itchy, scalp and body itchy, injection site red and swollen. Can't eat.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Pyrexia
Clinical narrative: Fatigue, sore throat, weakness,  myalgia , pain in arm at the site, low grade fever, headache, itchy, scalp and body itchy, injection site red and swollen. Can't eat.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy, Pain, Sleep disorder
Clinical narrative: Swelling in the left armpit large and painful enough on the second night to wake me up  Minor body aches
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Vaccination complication
Clinical narrative: pretty affected by the first two doses/it was very hard; diarrhea for 10 days; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (pretty affected by the first two doses/it was very hard) and DIARRHOEA (diarrhea for 10 days) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     "No medical history was provided by the reporter.".  Concomitant products included HYDROXYZINE EMBONATE (HYDROXYZINE PAMOATE) for Anxiety, TRAZODONE for Sleep disorder.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (pretty affected by the first two doses/it was very hard) and DIARRHOEA (diarrhea for 10 days). At the time of the report, VACCINATION COMPLICATION (pretty affected by the first two doses/it was very hard) outcome was unknown and DIARRHOEA (diarrhea for 10 days) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was provided.   This case was linked to MOD-2021-342423 (Patient Link).
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Somnolence
Clinical narrative: For about 2 days, all I wanted to do was sleep.; Felt really fatigued; Blinding headache; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (For about 2 days, all I wanted to do was sleep.), HEADACHE (Blinding headache) and FATIGUE (Felt really fatigued) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 029K20A) for COVID-19 vaccination.     The patient's past medical history included Blood pressure low (The patient was on a ventilator for about a week because her blood pressure was 40) and Pacemaker insertion (cardiac). Concurrent medical conditions included Bradycardia.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced HEADACHE (Blinding headache). On 19-Feb-2021, the patient experienced SOMNOLENCE (For about 2 days, all I wanted to do was sleep.) and FATIGUE (Felt really fatigued). At the time of the report, SOMNOLENCE (For about 2 days, all I wanted to do was sleep.), HEADACHE (Blinding headache) and FATIGUE (Felt really fatigued) outcome was unknown.            No concomitant medications were provided. No treatment medications were reported.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Fatigue, Headache, Muscular weakness
Clinical narrative: pretty affected by the first two doses/it was very hard; felt weak; arm was weak; chills; headache for almost a month; fatigue; soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (pretty affected by the first two doses/it was very hard), ASTHENIA (felt weak), MUSCULAR WEAKNESS (arm was weak), CHILLS (chills) and HEADACHE (headache for almost a month) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included TRAZODONE and HYDROXYZINE EMBONATE (HYDROXYZINE PAMOATE) for an unknown indication.    On 30-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (pretty affected by the first two doses/it was very hard), ASTHENIA (felt weak), MUSCULAR WEAKNESS (arm was weak), CHILLS (chills), HEADACHE (headache for almost a month), FATIGUE (fatigue) and MYALGIA (soreness). At the time of the report, VACCINATION COMPLICATION (pretty affected by the first two doses/it was very hard), ASTHENIA (felt weak) and MUSCULAR WEAKNESS (arm was weak) outcome was unknown and CHILLS (chills), HEADACHE (headache for almost a month), FATIGUE (fatigue) and MYALGIA (soreness) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-342395 (Patient Link).